Decellularized adipose tissue
Soft tissue deformity caused by traumatic injuries, birth defects or surgery can seriously affect an individual’s mental wellbeing and physical mobility. A new process developed by Dr. Lauren Flynn of Queen’s University holds promise for reducing or even eliminating these problems.
Her process of decellularizing human adipose tissue (i.e. fat) produces a “bioscaffold” that, when implanted in the body, stimulates the natural regrowth of healthy tissue. The technology provides a more stable and effective alternative to existing soft-tissue repair strategies, and has the potential to be used
in a wide range of procedures, from tumour resections, burn repairs, and the correction of congenital defects to breast augmentation and facial rejuvenation.
Rideau Commercialization Network (RCN) partner PARTEQ Innovations
is currently helping Dr. Flynn commercialize the technology.
Return on Innovation
- Will create 20 highly skilled jobs within three years
- Making Ontario a leader in the reconstructive and cosmetic surgery markets
OCE©2012 Last updated 10/2012